- Home
- SHOT vs XTNT Comparison
SHOT vs XTNT Comparison
Compare SHOT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- XTNT
- Stock Information
- Founded
- SHOT 2018
- XTNT N/A
- Country
- SHOT United States
- XTNT United States
- Employees
- SHOT N/A
- XTNT N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHOT Health Care
- XTNT Health Care
- Exchange
- SHOT Nasdaq
- XTNT Nasdaq
- Market Cap
- SHOT 62.8M
- XTNT 74.1M
- IPO Year
- SHOT 2020
- XTNT N/A
- Fundamental
- Price
- SHOT $0.95
- XTNT $0.43
- Analyst Decision
- SHOT
- XTNT Strong Buy
- Analyst Count
- SHOT 0
- XTNT 1
- Target Price
- SHOT N/A
- XTNT $3.00
- AVG Volume (30 Days)
- SHOT 709.7K
- XTNT 82.6K
- Earning Date
- SHOT 11-26-2024
- XTNT 11-12-2024
- Dividend Yield
- SHOT N/A
- XTNT N/A
- EPS Growth
- SHOT N/A
- XTNT N/A
- EPS
- SHOT N/A
- XTNT N/A
- Revenue
- SHOT $180,174.00
- XTNT $113,862,000.00
- Revenue This Year
- SHOT N/A
- XTNT $31.82
- Revenue Next Year
- SHOT N/A
- XTNT $13.64
- P/E Ratio
- SHOT N/A
- XTNT N/A
- Revenue Growth
- SHOT 68.01
- XTNT 45.11
- 52 Week Low
- SHOT $0.55
- XTNT $0.43
- 52 Week High
- SHOT $7.50
- XTNT $1.45
- Technical
- Relative Strength Index (RSI)
- SHOT 39.44
- XTNT 23.88
- Support Level
- SHOT $0.91
- XTNT $0.61
- Resistance Level
- SHOT $1.20
- XTNT $0.54
- Average True Range (ATR)
- SHOT 0.09
- XTNT 0.03
- MACD
- SHOT -0.01
- XTNT -0.01
- Stochastic Oscillator
- SHOT 13.49
- XTNT 0.00
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.